BGLAP and Hepatic steatosis: Further animal studies have demonstrated that short-term osteocalcin treatment in mice can mitigate hepatic steatosis.[35] Furthermore, bone harbors a substantial population of mesenchymal stem cells, which have been shown to modulate CD4 T cell differentiation in murine models, consequently alleviating nonalcoholic liver steatosis.[36] Although there is currently no clear research on the relationship between BMD and liver enzymes, the above indirect findings may help partially explain the relationship between BMD and ALT.